Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
219.00    -2.00 (-0.90%)
Bid:
218.00
Ask:
219.00
Spread: 1.00 (0.459%)
Market Cap: £605.35m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Q1 Trading Update

23 Apr 2018 07:00

RNS Number : 7079L
Morgan Advanced Materials PLC
23 April 2018
Β 

Β 

Β 

Press Release

Β 

Morgan Advanced Materials plc

23 April 2018

Q1 trading update

Β 

Sales for the first three months to March 2018 were 6.5% higher for the Group, on an organic constant currency basis, compared to the first quarter of last year.

Β 

By business, the organic constant currency trends for the first quarter compared to prior year are as follows. Sales for the Thermal Products division were 6.2% higher than the prior year, with growth in Asia and Europe. Within the Carbon and Technical Ceramics division, sales were 9.0% higher than last year, with above trend growth in Seals & Bearings driven by ceramic armour sales, good growth in Electrical Carbon, and modest growth in Technical Ceramics. The Composites and Defence Systems business has continued its recent declining trend.

Β 

Morgan Advanced Materials plc also announces that the Board has decided to exit the Composite and Defence Systems business. This exit will take the form of the potential divestment of certain product lines, should a suitable acquirer be found, together with the closure of the remainder of the business lines. Discussions with potential acquirers of certain product lines are at a very early stage, and there can be no certainty that any divestments will be made.

Β 

The provisional cash exit costs from closing the Composites and Defence Systems business are anticipated to be around Β£6Β million, which may be partially offset by any proceeds from the divestment of certain product lines and the sale of certain fixed assets of the business.

Β 

Looking forward to the balance of the year for the Group as a whole, the growth rate achieved in the first quarter is higher than we anticipate for the full year, reflecting a relatively weaker comparator period in the first quarter of the prior year. We currently anticipate that full year headline operating profit margins will be slightly ahead of the prior year, with the benefits of pricing, efficiency savings and volume leverage being partially offset by the planned reinvestment in research and development and sales resources, as well as the dilutive impact of the divestments completed in 2017.

Β 

This announcement contains inside information, the person responsible for releasing this announcement on behalf of the company is Peter Turner.

For further enquiries:

Β 

Pete Raby

Morgan Advanced Materials plc

01753 837 000

Peter Turner

Β 

Alison Kay

Β 

Brunswick

Β 

0207 404 5959

Β 

Notes:

The next scheduled update is the Group's half-year results presentation on 26 July 2018.

Legal Entity Identifier: I4K14LL95N2PHDL7EG85

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTZXLBLVZFXBBD
Date   Source Headline
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update
17th Oct 20222:21 pmRNSDirector/PDMR Shareholding
26th Sep 202212:52 pmRNSDirector/PDMR Shareholding
26th Sep 202212:49 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHalf-year results
15th Jun 20229:30 amRNSBlock listing Interim Review
1st Jun 202210:00 amRNSDirector/PDMR Shareholding
31st May 202210:06 amRNSDirector/PDMR Shareholding
24th May 20222:32 pmRNSDirector/PDMR Shareholding
16th May 20222:52 pmRNSDirector/PDMR Shareholding
5th May 20223:12 pmRNSDirectorate Change
5th May 20222:00 pmRNSResult of AGM
5th May 20227:00 amRNSQ1 trading update
3rd May 20222:45 pmRNSHolding in Company
14th Apr 20222:59 pmRNSHolding(s) in Company
30th Mar 20223:25 pmRNSAnnual Financial Report
28th Mar 202212:00 pmRNSHolding in Company
23rd Mar 202211:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.